Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 300

1.

Adjuvant chemotherapy for radically resected non-small cell lung cancer: a retrospective analysis of 311 consecutively treated patients.

Dediu M, Horvat T, Tarlea A, Anghel R, Cordos I, Miron G, Iorga P, Alexandru A, Nistor C, Grozavu C, Savu C.

Lung Cancer. 2005 Jan;47(1):93-101.

PMID:
15603859
2.

Compliance with adjuvant chemotherapy in non-small cell lung cancer. The experience of a single institution evaluating a cohort of 356 patients.

Dediu M, Alexandru A, Median D, Anghel R, Tarlea A, Iorga P, Movanu M.

J BUON. 2006 Oct-Dec;11(4):425-32.

PMID:
17309173
3.

Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell Lung cancer.

Scagliotti GV, Fossati R, Torri V, Crinò L, Giaccone G, Silvano G, Martelli M, Clerici M, Cognetti F, Tonato M; Adjuvant Lung Project Italy/European Organisation for Research Treatment of Cancer-Lung Cancer Cooperative Group Investigators.

J Natl Cancer Inst. 2003 Oct 1;95(19):1453-61.

PMID:
14519751
4.

Postoperative adjuvant chemotherapy and radiotherapy for stage II and III non-small cell lung cancer (NSCLC).

Lee SW, Choi EK, Chung WK, Shin KH, Ahn SD, Kim JH, Kim SW, Suh C, Lee JS, Kim WS, Kim DS, Kim DK, Park SI, Sohn KH.

Lung Cancer. 2002 Jul;37(1):65-71.

PMID:
12057869
5.

Concurrent cisplatin/etoposide plus 3D-conformal radiotherapy followed by surgery for stage IIB (superior sulcus T3N0)/III non-small cell lung cancer yields a high rate of pathological complete response.

Pourel N, Santelmo N, Naafa N, Serre A, Hilgers W, Mineur L, Molinari N, Reboul F.

Eur J Cardiothorac Surg. 2008 May;33(5):829-36. doi: 10.1016/j.ejcts.2008.01.063. Epub 2008 Mar 25.

PMID:
18367406
6.

Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgery.

Caglar HB, Baldini EH, Othus M, Rabin MS, Bueno R, Sugarbaker DJ, Mentzer SJ, Jänne PA, Johnson BE, Allen AM.

Cancer. 2009 Sep 15;115(18):4156-66. doi: 10.1002/cncr.24492.

7.

A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer.

Roth JA, Fossella F, Komaki R, Ryan MB, Putnam JB Jr, Lee JS, Dhingra H, De Caro L, Chasen M, McGavran M, et al.

J Natl Cancer Inst. 1994 May 4;86(9):673-80.

PMID:
8158698
8.

[Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].

Cai Y, Wang WL, Xu B, Zhu GY, Zhang SW.

Ai Zheng. 2006 Nov;25(11):1419-22. Chinese.

PMID:
17094913
9.

Postoperative adjuvant therapy for stage II non-small-cell lung cancer.

Park JH, Shim YM, Baek HJ, Kim MS, Choe DH, Cho KJ, Lee CT, Zo JI.

Ann Thorac Surg. 1999 Nov;68(5):1821-6.

PMID:
10585065
10.

Long term results of surgery and chemotherapy in small cell lung cancer.

Rea F, Callegaro D, Favaretto A, Loy M, Paccagnella A, Fantoni U, Festi G, Sartori F.

Eur J Cardiothorac Surg. 1998 Oct;14(4):398-402.

PMID:
9845145
11.

[Postoperative adjuvant therapy for 189 patients with completely resected non-small cell lung cancer of stage III(A)].

Li Q, Gao JM, Liang PY, Xie FY, Liu GZ.

Ai Zheng. 2004 Nov;23(11 Suppl):1463-6. Chinese.

PMID:
15566658
12.

Surgery and chemotherapy for small cell lung cancer in stages I-II with or without radiotherapy.

Bischof M, Debus J, Herfarth K, Muley T, Kappes J, Storz K, Hoffmann H.

Strahlenther Onkol. 2007 Dec;183(12):679-84.

PMID:
18040612
13.

Patterns of care survey (PCS) in lung cancer: how well does current U.S. practice with chemotherapy in the non-metastatic setting follow the literature?

Langer CJ, Moughan J, Movsas B, Komaki R, Ettinger D, Owen J, Wilson JF.

Lung Cancer. 2005 Apr;48(1):93-102.

PMID:
15777975
14.

Impact of postoperative radiation therapy on survival in patients with complete resection and stage I, II, or IIIA non-small-cell lung cancer treated with adjuvant chemotherapy: the adjuvant Navelbine International Trialist Association (ANITA) Randomized Trial.

Douillard JY, Rosell R, De Lena M, Riggi M, Hurteloup P, Mahe MA; Adjuvant Navelbine International Trialist Association.

Int J Radiat Oncol Biol Phys. 2008 Nov 1;72(3):695-701. doi: 10.1016/j.ijrobp.2008.01.044. Epub 2008 Apr 24.

PMID:
18439766
16.

Which patients should be operated on after induction chemotherapy for N2 non-small cell lung cancer? Analysis of a 7-year experience in 175 patients.

Stefani A, Alifano M, Bobbio A, Grigoroiu M, Jouni R, Magdeleinat P, Regnard JF.

J Thorac Cardiovasc Surg. 2010 Aug;140(2):356-63. doi: 10.1016/j.jtcvs.2010.02.018. Epub 2010 Apr 9.

17.

Postoperative adjuvant cisplatin, vindesine, plus uracil-tegafur chemotherapy increased survival of patients with completely resected p-stage I non-small cell lung cancer.

Imaizumi M; Study Group of Adjuvant Chemotherapy for Lung Cancer (Chubu, Japan).

Lung Cancer. 2005 Jul;49(1):85-94.

PMID:
15949594
18.

Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial.

Waller D, Peake MD, Stephens RJ, Gower NH, Milroy R, Parmar MK, Rudd RM, Spiro SG.

Eur J Cardiothorac Surg. 2004 Jul;26(1):173-82.

PMID:
15200998
19.

Supplemental Content

Support Center